Comparison of frequency of hemorrhagic stroke in patients <75 years versus ≥75 years of age among patients receiving glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions

Ioannis Iakovou, George Dangas, Gary S. Mintz, Roxana Mehran, Alexandra J. Lansky, Eve D. Aymong, Eugenia Nikolsky, Tudor Vagaonescu, Lynne A. Glasser, Gregg W. Stone, Martin B. Leon, Jeffrey W. Moses

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

We identified 1,369 consecutive patients who received glycoprotein IIb/ IIIa inhibitors during 1,461 stenting procedures (2,382 lesions); of these, 240 (17.5%) were aged ≥75 years (253 procedures, 430 lesions). Very elderly patients (≥75 years) had similar in-hospital outcomes but a higher hemorrhagic stroke rate than patients aged <75 years.

Original languageEnglish
Pages (from-to)346-349
Number of pages4
JournalAmerican Journal of Cardiology
Volume93
Issue number3
DOIs
StatePublished - 1 Feb 2004
Externally publishedYes

Fingerprint

Dive into the research topics of 'Comparison of frequency of hemorrhagic stroke in patients <75 years versus ≥75 years of age among patients receiving glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions'. Together they form a unique fingerprint.

Cite this